OraSure Technologies | OSUR - Cash And Equivalent


OraSure Technologies reported $199.28M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Agilent USD 1.76B 31M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 507.2M 22.6M Mar/2026
Bruker USD 293.1M 201.1M Sep/2025
Cerus USD 19.96M 4.29M Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 5.7B 1.09B Mar/2026
Dentsply International USD 190M 136M Mar/2026
Dexcom USD 1.12B 200.5M Mar/2026
Illumina USD 1.42B 368M Dec/2025
Integra LifeSciences USD 236.81M 1.76M Mar/2026
Intuitive Surgical USD 7.98B 1.05B Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Quidel USD 169.8M 71.7M Dec/2025
Repligen USD 566.02M 182.73M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Trinity Biotech USD 1.34M 3.83M Sep/2025
Waters USD 587.83M 128.71M Dec/2025